Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.

Saved in:
Bibliographic Details
Title: Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Authors: Krauss AH; Department of Biological Sciences, Allergan, Inc., Irvine, CA 92713-9534, USA., Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J
Source: British journal of pharmacology [Br J Pharmacol] 1996 Mar; Vol. 117 (6), pp. 1171-80.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Print ISSN: 0007-1188 (Print) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0007-1188
DOI:10.1111/j.1476-5381.1996.tb16712.x